ꢀ
P. Stꢀepꢁanek et al. / Tetrahedron: Asymmetry 15 (2004) 1033–1041
1039
1H, J ¼ 5.5 Hz, J ¼ 2.1 Hz, H-2), 4.95–4.43 (m, 8H,
4 · C6H5–CH2), 4.17 (m, 1H, H-20), 3.92 (dq, 1H,
J ¼ 9.6 Hz, J ¼ 7.0 Hz, –O–CH2–CH3), 3.79–3.54 (m,
7H, H-30, H-40, H-50, H-60, H-70a, H-70b, –O–CH2–CH3),
2.58 (m, 1H, H-4), 2.06 (m, 2H, H-10a, H-10b), 1.90 (m,
1H, H-3eq), 1.76 (ddd, 1H, J ¼ 13.8 Hz, J ¼ 5.5 Hz,
J ¼ 5.5 Hz, H-3ax), 1.19 (t, 3H, J ¼ 7.0 Hz, –O–CH2–
CH3). 13C NMR (125 MHz, CDCl3) d (ppm): 186.96
(–CH@O), 149.45 (C-6), 138.57, 138.07, 138.01, 137.79
(4 · ipso C6H5–CH2), 128.50–127.65 (20 · C6H5–CH2,
C-5), 98.57 (C-2), 82.24, 79.73, 78.07, 72.11, 71.38 (C-20,
C-30, C-40, C-50, C-60), 75.47, 75.05, 73.52, 73.06
(4 · C6H5–CH2), 69.12 (C-70), 64.58 (–O–CH2–CH3),
31.82 (C-3), 29.36 (C-10), 27.97 (C-4), 15.15 (–O–CH2–
CH3). MS (ESI): 715.2 (M+Na)þ.
(C-60), 68.79 (C-50), 64.76 (–O–CH2–CH3), 62.88 (C-6),
62.40 (C-70), 37.39 (C-3), 37.23 (C-2), 27.16 (C-10),
20.80–20.58 (6 · O@C–CH3), 15.04 (–O–CH2–CH3). MS
(ESI): 627.3 (M+Na)þ. HRMS (ESI): calcd for
C27H40NaO15 (M+Na)þ 627.2265, found 627.2286.
4.8. Ethyl 2,3-dideoxy-3-C-(20,60-anhydro-30,40,50,70-tetra-
O-acetyl-10-deoxy-
D
-glycero-
-arabino-hexopyranoside 19
D
-ido-heptitol-10-yl)-4,6-di-
O-acetyl-b-
L
The title compound 19 was prepared from aldehyde 15
(2.6 g) in the same manner as described in the preceding
experiment. Yield 1.72 g (76%) of 19, mp 149–151 ꢁC
(acetone/light petroleum).
RF ¼ 0:3 (light petroleum/ether, 1:4). ½aꢁ ¼ þ85:9 (c 1,
D
4.7. Ethyl 2,3-dideoxy-3-C-(20,60-anhydro-30,40,50,70-tetra-
CHCl3). 1H NMR (CDCl3): d (ppm) 5.24 (dd, 1H,
J ¼ 8.9 Hz, J ¼ 9.2 Hz, H-40), 5.06 (dd, 1H, J ¼ 9.2 Hz,
J ¼ 5.8 Hz, H-30), 4.91 (dd, 1H, J ¼ 8.9 Hz, J ¼ 8.9 Hz,
H-50), 4.73 (dd, 1H, J ¼ 10.0 Hz, J ¼ 10.0 Hz, H-4), 4.52
(dd, 1H, J ¼ 1.5 Hz, J ¼ 9.6 Hz, H-1), 4.26 (m, 2H, H-1,
H-6a), 4.18 (m, 2H, H-70a, H-70b), 4.07 (dd, 1H,
J ¼ 2.4 Hz, J ¼ 12.1 Hz, H-6b), 3.94 (dq, 1H, J ¼ 7.1 Hz,
J ¼ 9.3 Hz, –O–CH2–CH3), 3.80 (m, 1H, H-60), 3.59–
3.50 (m, 2H, H-5, –O–CH2–CH3), 2.14–2.01 (m, 19H,
6 · O@C–CH3, H-3), 1.92 (m, 2H, H-2eq, H-10a), 1.40
(ddd, 1H, J ¼ 9.6 Hz, J ¼ 9.6 Hz, J ¼ 12.8 Hz, H-2ax),
1.29–1.20 (m, 4H, –O–CH2–CH3, H-10b). 13C NMR
(125 MHz, CDCl3) d (ppm): 170.85, 170.50, 170.24,
169.92, 2 · 169.51 (6 · O@C–CH3), 101.06 (C-1), 74.73
(C-5), 70.40 (C-4), 70.03 (C-30), 69.90 (C-40), 68.89
(C-50), 68.78 (C-60), 68.60 (C-20), 64.79 (–O–CH2–CH3),
63.06 (C-6), 62.27 (C-70), 35.13 (C-2), 34.55 (C-3),
26.64 (C-10), 20.85–20.61 (6 · O@C–CH3), 15.06 (–O–
CH2–CH3). MS (ESI): 627.3 (M+Na)þ. HRMS (ESI):
calcd for C27H40NaO15 (M+Na)þ 627.2265, found
627.2295.
O-acetyl-10-deoxy-
D
-glycero-
-arabino-hexopyranoside 18
D
-ido-heptitol-10-yl)-4,6-di-
O-acetyl-b-
D
A 2 M solution of BH3ÆS(CH3)2 in tetrahydrofuran
(4.5 mL, 9 mmol) was added dropwise to a solution
of aldehyde 14 (2.29 g, 3.3 mmol) in tetrahydrofuran
(70 mL), precooled to 0 ꢁC, and the reaction mixture
stirred at room temperature for 16 h. Then a 30% solu-
tion of NaOH (3.7 mL) and 30% solution of H2O2
(3.7 mL) was added and after stirring at room temper-
ature for 30 min the reaction mixture was partitioned
between ethyl acetate and saturated NaCl solution. The
organic phase was dried, the solvent evaporated in
vacuo and the residue dissolved in ethanol (150 mL) and
hydrogenated over Pd/C (10%, 0.9 g) under atmospheric
pressure. After 8 h, the catalyst was filtered off and the
solvent evaporated. The residue was dissolved in pyri-
dine (25 mL), acetic anhydride (10 mL) and dimethyl-
aminopyridine (0.1 g) then added and the mixture stirred
at room temperature for 1 h. The reaction mixture was
poured onto ice, partitioned between water and ethyl
acetate and the organic phase, after drying and evapo-
ration of the solvent, was chromatographed on silica
gel in light petroleum/ether (1:4). Yield 1.5 g (75%)
of compound 18, mp 159–162 ꢁC (acetone/light petro-
leum).
4.9. Ethyl 2,3-dideoxy-3-C-(20,60-anhydro-30,40,50,70-tetra-
O-acetyl-10-deoxy-
D
-glycero-
-arabino-hexopyranoside 20
D
-ido-heptitol-10-yl)-4,6-di-
O-acetyl-a-
L
Aldehyde 15 was treated as described in Section 4.7,
except that a Pd-catalyst containing traces of acid, was
employed. Crystallization from acetone/light petroleum
of the obtained mixture of 19 and 20 afforded an ana-
lytical sample of the title compound 20, mp 137–139 ꢁC
(acetone/light petroleum). RF ¼ 0:3 (light petroleum/
RF ¼ 0:35 (light petroleum/ether, 1:4). ½aꢁ ¼ þ21:3 (c 1,
D
CHCl3). 1H NMR (CDCl3): d (ppm) 5.23 (dd, 1H,
J ¼ 9.2 Hz, J ¼ 9.6 Hz, H-40), 4.97 (dd, 1H, J ¼ 9.6 Hz,
J ¼ 5.8 Hz, H-30), 4.93 (dd, 1H, J ¼ 9.1 Hz, J ¼ 9.2 Hz,
H-50), 4.74 (dd, 1H, J ¼ 10.0 Hz, J ¼ 10.0 Hz, H-4), 4.52
(dd, 1H, J ¼ 1.3 Hz, J ¼ 9.3 Hz, H-1), 4.27 (dd, 1H,
J ¼ 4.9 Hz, J ¼ 12.1 Hz, H-6a), 4.20 (m, 2H, H-70a, H-
20), 4.11 (dd, 1H, J ¼ 2.1 Hz, J ¼ 12.1 Hz, H-70b), 4.04
(dd, 1H, J ¼ 2.2 Hz, J ¼ 12.1 Hz, H-6b), 3.95 (dq, 1H,
J ¼ 7.2 Hz, J ¼ 9.4 Hz, –O–CH2–CH3), 3.85 (m, 1H, H-
60), 3.59–3.50 (m, 2H, H-5, –O–CH2–CH3), 2.20 (m, 1H,
H-2eq), 2.14–2.01 (m, 18H, 6 · O@C–CH3), 1.90 (m,
1H, H-3), 1.64 (m, 2H, H-10a, H-10b), 1.51 (ddd, 1H,
J ¼ 12.8 Hz, J ¼ 9.3 Hz, J ¼ 9.3 Hz, H-2ax), 1.23 (t, 3H,
J ¼ 7.2 Hz, –O–CH2–CH3). 13C NMR (125 MHz,
CDCl3) d (ppm): 170.86, 170.63, 170.30, 169.91, 169.63,
169.52 (6 · O@C–CH3), 101.00 (C-1), 74.52 (C-5), 73.16
(C-20), 71.42 (C-4), 70.19 (C-30), 69.75 (C-40), 69.01
ether, 1:4). ½aꢁ ¼ þ21:5 (c 1, CHCl3). 1H NMR
D
(CDCl3): d (ppm) 5.24 (dd, 1H, J ¼ 9.1 Hz, J ¼ 9.3 Hz,
H-40), 5.06 (dd, 1H, J ¼ 9.3 Hz, J ¼ 5.9 Hz, H-30), 4.92
(dd, 1H, J ¼ 9.1 Hz, J ¼ 9.1 Hz, H-50), 4.87 (d, 1H,
J ¼ 3.4 Hz, H-1), 4.75 (dd, 1H, J ¼ 10.2 Hz, J ¼ 10.2 Hz,
H-4), 4.28–4.20 (m, 3H, H-20, H-70a, H-6a), 4.11 (dd,
1H, J ¼ 2.1 Hz, J ¼ 12.1 Hz, H-70b), 4.01 (dd, 1H,
J ¼ 2.1 Hz, J ¼ 12.1 Hz, H-6b), 3.88 (ddd, 1H,
J ¼ 2.1 Hz, J ¼ 4.5 Hz, J ¼ 10.2 Hz, H-5), 3.80 (ddd, 1H,
J ¼ 2.1 Hz, J ¼ 5.5 Hz, J ¼ 9.1 Hz, H-60), 3.68 (dq, 1H,
J ¼ 7.1 Hz, J ¼ 9.6 Hz, –O–CH2–CH3), 3.48 (dq, 1H,
J ¼ 7.1 Hz, J ¼ 9.6 Hz, –O–CH2–CH3), 2.23 (m, 1H,
H-3), 2.14–2.01 (m, 19H, 6 · O@C–CH3, H-2eq), 1.89